Henry Schein, Inc. (NASDAQ:HSIC) Shares Sold by Wells Fargo & Company MN

Wells Fargo & Company MN lessened its holdings in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) by 79.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 55,423 shares of the company's stock after selling 220,671 shares during the quarter. Wells Fargo & Company MN's holdings in Henry Schein were worth $3,835,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds have also recently modified their holdings of the business. Smartleaf Asset Management LLC lifted its position in Henry Schein by 23.2% during the fourth quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after purchasing an additional 143 shares in the last quarter. CIBC Asset Management Inc lifted its position in shares of Henry Schein by 1.0% during the 4th quarter. CIBC Asset Management Inc now owns 17,849 shares of the company's stock valued at $1,235,000 after buying an additional 169 shares in the last quarter. Metis Global Partners LLC grew its stake in shares of Henry Schein by 4.7% during the 4th quarter. Metis Global Partners LLC now owns 4,203 shares of the company's stock valued at $291,000 after acquiring an additional 187 shares during the period. Central Pacific Bank Trust Division increased its holdings in Henry Schein by 2.0% in the 4th quarter. Central Pacific Bank Trust Division now owns 10,200 shares of the company's stock worth $706,000 after acquiring an additional 200 shares in the last quarter. Finally, Sanctuary Advisors LLC raised its stake in Henry Schein by 5.0% during the 4th quarter. Sanctuary Advisors LLC now owns 4,253 shares of the company's stock worth $294,000 after acquiring an additional 203 shares during the period. Institutional investors own 96.62% of the company's stock.

Wall Street Analyst Weigh In

A number of research firms have weighed in on HSIC. Wells Fargo & Company started coverage on shares of Henry Schein in a research report on Friday, February 14th. They issued an "equal weight" rating and a $80.00 price target for the company. Bank of America raised shares of Henry Schein from an "underperform" rating to a "buy" rating and upped their target price for the stock from $69.00 to $84.00 in a report on Monday, January 6th. StockNews.com lowered Henry Schein from a "buy" rating to a "hold" rating in a research note on Thursday, April 17th. Jefferies Financial Group lifted their target price on Henry Schein from $77.00 to $80.00 and gave the company a "hold" rating in a research note on Thursday, January 23rd. Finally, UBS Group dropped their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a research note on Wednesday, February 26th. Six equities research analysts have rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $81.10.

Henry Schein Price Performance

Shares of NASDAQ HSIC traded down $1.06 during mid-day trading on Friday, hitting $65.17. 736,945 shares of the company's stock traded hands, compared to its average volume of 1,619,867. The company's 50-day moving average is $69.21 and its two-hundred day moving average is $71.78. The company has a debt-to-equity ratio of 0.46, a current ratio of 1.42 and a quick ratio of 0.82. Henry Schein, Inc. has a 1 year low of $60.56 and a 1 year high of $82.49. The company has a market capitalization of $7.98 billion, a P/E ratio of 26.82, a PEG ratio of 2.13 and a beta of 0.84.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). The company had revenue of $3.19 billion for the quarter, compared to the consensus estimate of $3.25 billion. Henry Schein had a net margin of 2.51% and a return on equity of 12.90%. The business's revenue for the quarter was up 5.8% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.66 EPS. On average, equities analysts anticipate that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Insider Activity at Henry Schein

In other news, CEO Bradford C. Connett sold 4,036 shares of Henry Schein stock in a transaction on Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the sale, the chief executive officer now directly owns 62,688 shares in the company, valued at approximately $4,460,251.20. This trade represents a 6.05 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, Director Philip A. Laskawy sold 2,604 shares of the business's stock in a transaction on Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now directly owns 24,805 shares of the company's stock, valued at $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by insiders.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.